Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Potency of carbapenems for the prevention of carbapenem-resistant mutants of Pseudomonas aeruginosa: the high potency of a new carbapenem doripenem.

The Journal of antibiotics - 1 Apr 2006

Sakyo Shihomi, Tomita Haruyoshi, Tanimoto Koichi, Fujimoto Shuhei, Ike Yasuyoshi

Abstract excerpt

The potencies of the carbapenems; doripenem (DRPM), meropenem (MEPM) and imipenem (IPM) in preventing the emergence of carbapenem-resistant mutants were examined in Pseudomonas aeruginosa strains. The carbapenems predominantly selected carbapenem-resistant mutants or carbapenem mutants with reduced susceptibilities that were specifically resistant to carbapenems and had arisen as a result of the reduced level of...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Bacterial Outer Membrane Proteins
Share to Carbapenems

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Colony Count, Microbial

Share to Imipenem

Share to Meropenem

Share to Molecular Weight

Share to Pseudomonas aeruginosa

Share to Thienamycins

Source

Identifiers

PMID: 16830889
DOI: 10.1038/ja.2006.31

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Potency of carbapenems for the prevention of carbapenem-resistant mutants of Pseudomonas aeruginosa: the high potency of a new carbapenem doripenem.PMID 16830889Read ↗

Fluoroquinolone enhances the mutation frequency for meropenem-selected carbapenem resistance in Pseudomonas aeruginosa, but use of the high-potency drug doripenem inhibits mutant formation.Semantic proximity Read ↗

Doripenem versus Pseudomonas aeruginosa in vitro: activity against characterized isolates, mutants, and transconjugants and resistance selection potential.Semantic proximity Read ↗

Carbapenem resistance in clinical isolates of Pseudomonas aeruginosa.Semantic proximity Read ↗

Carbapenem activities against Pseudomonas aeruginosa: respective contributions of OprD and efflux systems.Semantic proximity Read ↗

Reduced production of OprM may promote oprD mutations and lead to imipenem resistance in Pseudomonas aeruginosa carrying an oprD-group 1A allele.Semantic proximity Read ↗

Enhanced in vivo fitness of carbapenem-resistant oprD mutants of Pseudomonas aeruginosa revealed through high-throughput sequencing.Semantic proximity Read ↗

Characterization of clinical isolates of Pseudomonas aeruginosa heterogeneously resistant to carbapenems.Semantic proximity Read ↗

AmpC induction by imipenem in Pseudomonas aeruginosa occurs in the absence of OprD and impacts imipenem/relebactam susceptibilitySemantic proximity Read ↗

Carbapenem Resistance Mechanisms in Pseudomonas aeruginosa Clinical IsolatesSemantic proximity Read ↗

Development of carbapenem resistance in Pseudomonas aeruginosa is associated with OprD polymorphisms, particularly the amino acid substitution at codon 170.Semantic proximity Read ↗

Activity of Imipenem-Relebactam against a Large Collection of Pseudomonas aeruginosa Clinical Isolates and Isogenic β-Lactam-Resistant Mutants.Semantic proximity Read ↗

Mutational inactivation of OprD in carbapenem-resistant Pseudomonas aeruginosa isolates from Korean hospitals.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.